Hypha Labs Inc (DIGP)
0.033
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Hypha Labs Enterprise Value: 5.251M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 5.251M |
| May 15, 2024 | 5.208M |
| May 14, 2024 | 5.051M |
| May 13, 2024 | 5.073M |
| May 10, 2024 | 4.990M |
| May 09, 2024 | 4.807M |
| May 08, 2024 | 5.277M |
| May 07, 2024 | 5.338M |
| May 06, 2024 | 5.277M |
| May 03, 2024 | 5.161M |
| May 02, 2024 | 5.234M |
| May 01, 2024 | 5.687M |
| April 30, 2024 | 5.208M |
| April 29, 2024 | 5.114M |
| April 26, 2024 | 5.114M |
| April 25, 2024 | 5.242M |
| April 24, 2024 | 5.242M |
| April 23, 2024 | 5.251M |
| April 22, 2024 | 4.859M |
| April 19, 2024 | 5.351M |
| April 18, 2024 | 4.317M |
| April 17, 2024 | 4.310M |
| April 16, 2024 | 4.317M |
| April 15, 2024 | 4.07M |
| April 12, 2024 | 4.098M |
| Date | Value |
|---|---|
| April 11, 2024 | 4.084M |
| April 10, 2024 | 4.119M |
| April 09, 2024 | 4.010M |
| April 08, 2024 | 4.119M |
| April 05, 2024 | 4.528M |
| April 04, 2024 | 4.532M |
| April 03, 2024 | 4.964M |
| April 02, 2024 | 4.250M |
| April 01, 2024 | 3.892M |
| March 28, 2024 | 4.258M |
| March 27, 2024 | 4.981M |
| March 26, 2024 | 4.032M |
| March 25, 2024 | 3.945M |
| March 22, 2024 | 3.858M |
| March 21, 2024 | 3.875M |
| March 20, 2024 | 3.901M |
| March 19, 2024 | 3.943M |
| March 18, 2024 | 3.972M |
| March 15, 2024 | 3.949M |
| March 14, 2024 | 3.949M |
| March 13, 2024 | 3.866M |
| March 12, 2024 | 4.023M |
| March 11, 2024 | 3.901M |
| March 08, 2024 | 3.814M |
| March 07, 2024 | 3.866M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.158M
Minimum
Mar 18 2020
7.841M
Maximum
May 23 2019
4.215M
Average
4.055M
Median
Nov 29 2021
Enterprise Value Benchmarks
| Fonar Corp | 40.71M |
| XWELL Inc | -7.53M |
| ProPhase Labs Inc | 108.93M |
| Applied DNA Sciences Inc | -0.569M |
| Veracyte Inc | 1.580B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.1516M |
| Total Expenses (Quarterly) | 0.0706M |
| EPS Diluted (Quarterly) | 0.0017 |
| Earnings Yield | 13.37% |
| Normalized Earnings Yield | -27.02 |